Custom Peptide Libraries
Mabtech Inc PepPool: CMV (CD4 and CD8), human, 25 μg of each peptide, lyophilized, 42 peptides, >95% purity, MHC class I: 28, MHC class II: 14
PepPool: CMV (CD4 and CD8), human, 25 μg of each peptide, lyophilized, 42 peptides, >95% purity, MHC class I: 28, MHC class II: 14
AnaSpec CEF Control Peptide Pool, (1 mg)
CEF Control Peptide Pool, (1 mg) This product contains 0.03 mg (net) of the 32 CEF peptides for a total of 1 mg in one vial. Used in the stimulation of IFNy release from CD8+ T cells in individuals with defined HLA types, these epitopes are useful in applications such as ELISPOT, intracellular cytokine and CTL assays.
Bioss KD-Validated Trophoblast Glyco
Trophoblast Glycoprotein Primary Antibody Unconjugated Public Immunogen Range 230-280/366 Host Species Rabbit Target Species Human Clonality Monoclonal Applications WB Concentration Lot dependent Size 50 ul Storage Buffer Supplied in PBS (pH 7 4) containing 50% glycerol and 0 02% sodium azide
Cayman Chemical 1 3DIlnoloyl2oloyl Glyc 50mg
A triacylglycerol; has been found in grape seed, pumpkin seed, soybean, sunflower, and wheat germ oils
Biolegend Spark YGTM 581 anti-mouse I-A/
Spark YG™ 581 anti-mouse I-A/I-E [M5/114.15.2]; Isotype: Rat IgG2b, κ; Reactivity: Mouse; Apps: FC; Size: 25 μg
STEMCELL Technologies CMV HLA Class I Control Peptid, 1 Unit
Cytomegalovirus CMV control peptide pool for immune cell activation
STEMCELL Technologies SARS-CoV-2 Spike Protein Omicr, 1 Unit
SARS-CoV-2 spike protein Omicron XBB.1.5.X variant peptide pool for immune cell activation
Genscript Corporation SARS-CoV-2 Spike protein RBD
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases Recently the new B 1 1 529 variant was confirmed in South Africa and preliminary evidence suggests an increased risk of reinfection with this variant The B 1 1 529 variant was first reported to WHO on 24 November 2021 and WHO has designated this variant as a VOC (Variant of Concern) named Omicron There are more than 30 mutations in the spike protein
Mabtech Inc CEF peptide pool for human CD8 T cells
The CEF peptide pool stimulates CD8+ T cells to produce preferentially IFN-γ and is recommended as a positive control in IFN-γ ELISpot and FluoroSpot assays using human PBMC. The CEF peptide pool consists of 23 MHC class I-restricted viral peptides from human CMV, EBV and influenza virus. It has been shown to induce IFN-γ responses in almost 90% of all Caucasians.
